People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gyroscope Therapeutics Ltd | — | Biotechnology | Series D+ | $148.0M | $4.8B | 2021 |
Nadia Waheed at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nadia Waheed on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Maha Katabi | 1 | 6 |
| Ian Clark | 1 | 5 |
| Renee Gala | 1 | 2 |
| David Fellows | 1 | 2 |
| Chris Hollowood | 1 | 2 |
| Sean Bohen | 1 | 2 |
| Edward Lang | 1 | 2 |
| Khurem Farooq | 1 | 1 |
| Ian Pitfield | 1 | 1 |
| Jennifer Cook | 1 | 1 |
| Jane Hughes | 1 | 1 |
| Wouter Joustra | 1 | 1 |
| Jessica Stitt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.